Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays ClinicalTrials.gov navigation and footer elements instead of the 403 error response, but the study record content is not visible.
    Difference
    0.6%
    Check dated 2026-10-31T12:58:50.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T16:32:47.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:23:10.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:23:36.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden message and a Home link in place of the study record.
    Difference
    0.5%
    Check dated 2026-10-03T16:13:43.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of showing the study record content, indicating that access to the record is blocked. The surrounding site chrome remains, but the study details cannot be viewed.
    Difference
    19%
    Check dated 2026-09-19T21:59:55.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.